Developing Novel Therapy for Neurological Diseases Associated with Dysregulated Brain Cortisol|Steven Gourlay , CEO, Actinogen Medical Ltd. 00:10:00
The CEO of a biotechnology company discusses the development of a novel therapy targeting neurological diseases linked to dysregulated brain cortisol, emphasizing its potential impact on conditions like Alzheimer’s Disease and Major Depressive Disorder.